MSL2 ensures biallelic gene expression in mammals.

Area of Science:

• Genetics
• Developmental Biology
• Epigenetics

Background:

• Diploid organisms require biallelic gene expression for adequate mRNA levels, crucial for haploinsufficient genes to prevent developmental disorders.
• The mechanisms determining cell-type-specific biallelic or monoallelic gene expression remain largely unknown.
• MSL2 protein is recognized for its role in dosage compensation of the male X chromosome in flies.

Purpose of the Study:

• To investigate the role of MSL2 in regulating allelic gene expression in mammals.
• To understand how MSL2 loss affects gene expression patterns, particularly for haploinsufficient genes.
• To explore the implications of MSL2-mediated allelic regulation in mammalian development and disease.

Main Methods:

• Allele-specific bulk and single-cell analyses were performed in mouse neural progenitor cells.
• Gene expression patterns were analyzed following MSL2 loss.
• Histone modifications, transcription factor binding, DNA methylation, and promoter-enhancer contacts were assessed.

Main Results:

• MSL2 loss caused a transition from biallelic to monoallelic expression in a subset of genes, many of which are haploinsufficient.
• In MSL2-deficient cells, one allele remained active with active histone marks and transcription factor binding, while the other was silenced.
• Silenced alleles showed loss of promoter-enhancer contacts and gained DNA methylation.
• Msl2-knockout mice exhibited perinatal lethality and heterogeneous developmental phenotypes.

Conclusions:

• MSL2 plays a critical role in preserving biallelic expression of dosage-sensitive genes in mammals.
• MSL2's function in regulating allelic gene dosage has significant implications for mammalian development and human diseases.
• Further research is warranted to identify other factors involved in mammalian allelic dosage compensation.